DEUTSCHE BANK AG\
BankPosition in RXRX — Recursion Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in RXRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,156,981
-$59,809 QoQ
Shares Held
376,867
+26.7% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. RXRX ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,156,981 | 376,867 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,216,790 | 297,504 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,315,447 | 269,559 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,212,815 | 239,687 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,091,696 | 206,370 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,471,806 | 217,723 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $933,993 | 141,729 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $824,077 | 109,877 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $808,386 | 81,082 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $772,500 | 78,347 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $456,612 | 59,688 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $386,310 | 51,715 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $591,361 | 88,660 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $547,201 | 70,973 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $617,864 | 58,070 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $523,547 | 64,318 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $471,120 | 65,799 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,247,080 | 72,801 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $385,692 | 16,762 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $478,953 | 13,122 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||